Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie L Felton

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Immunohorizons|July 15, 2021
Timing of Immunotherapy in Type 1 Diabetes: The Earlier, the Better?Jamie L Felton
JCEM Case Reports|March 16, 2026
Progression from Stage 1 to Stage 3 Type 1 Diabetes Characterized by HypoglycemiaAakash Nagarapu, Jamie L Felton
Biomolecules|May 4, 2026
Type I Interferons as Contextual Regulators of B-Cell Tolerance in Type 1 DiabetesMebrahtu G Tedla, Jamie L Felton
Biomedicines|January 9, 2021
B Quiet: Autoantigen-Specific Strategies to Silence Raucous B Lymphocytes and Halt Cross-Talk with T Cells in Type 1 DiabetesJamie L Felton, Holly Conway, Rachel H Bonami
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2018
Anti-Insulin B Cells Are Poised for Antigen Presentation in Type 1 DiabetesJamie L Felton, Damian Maseda, Rachel H Bonami, et al.
Diabetes Care|April 24, 2025
Type 1 Diabetes TrialNet: Leading the Charge in Disease Prediction, Prevention, and Immunotherapeutic Mechanistic UnderstandingLaura M Jacobsen, Jamie L Felton, Brandon M Nathan, et al.
The Journal of Clinical Endocrinology and Metabolism|April 2, 2025
Establishing Screening Programs for Presymptomatic Type 1 Diabetes: Practical Guidance for Diabetes Care ProvidersSteven B Leichter, Jamie L Felton, Cristy Geno Rasmussen, et al.
Diabetologia|October 13, 2021
HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participantsJamie L Felton, David Cuthbertson, Megan Warnock, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2020
T-B Lymphocyte Interactions Promote Type 1 Diabetes Independently of SLAM-Associated ProteinRachel H Bonami, Lindsay E Nyhoff, Dudley H McNitt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 27, 2025
Altered B cell metabolic pathways characterize type 1 diabetes progressionHolly Conway, Jessica Bernard, Rachel Ramos, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Immunohorizons|July 15, 2021
Timing of Immunotherapy in Type 1 Diabetes: The Earlier, the Better?Jamie L Felton
JCEM Case Reports|March 16, 2026
Progression from Stage 1 to Stage 3 Type 1 Diabetes Characterized by HypoglycemiaAakash Nagarapu, Jamie L Felton
Biomolecules|May 4, 2026
Type I Interferons as Contextual Regulators of B-Cell Tolerance in Type 1 DiabetesMebrahtu G Tedla, Jamie L Felton
Biomedicines|January 9, 2021
B Quiet: Autoantigen-Specific Strategies to Silence Raucous B Lymphocytes and Halt Cross-Talk with T Cells in Type 1 DiabetesJamie L Felton, Holly Conway, Rachel H Bonami
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2018
Anti-Insulin B Cells Are Poised for Antigen Presentation in Type 1 DiabetesJamie L Felton, Damian Maseda, Rachel H Bonami, et al.
Diabetes Care|April 24, 2025
Type 1 Diabetes TrialNet: Leading the Charge in Disease Prediction, Prevention, and Immunotherapeutic Mechanistic UnderstandingLaura M Jacobsen, Jamie L Felton, Brandon M Nathan, et al.
The Journal of Clinical Endocrinology and Metabolism|April 2, 2025
Establishing Screening Programs for Presymptomatic Type 1 Diabetes: Practical Guidance for Diabetes Care ProvidersSteven B Leichter, Jamie L Felton, Cristy Geno Rasmussen, et al.
Diabetologia|October 13, 2021
HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participantsJamie L Felton, David Cuthbertson, Megan Warnock, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2020
T-B Lymphocyte Interactions Promote Type 1 Diabetes Independently of SLAM-Associated ProteinRachel H Bonami, Lindsay E Nyhoff, Dudley H McNitt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 27, 2025
Altered B cell metabolic pathways characterize type 1 diabetes progressionHolly Conway, Jessica Bernard, Rachel Ramos, et al.
Pageof 3